|
|
Blood, 15 May 2005, Vol. 105, No. 10, pp. 3935-3938.
Prepublished online as a Blood First Edition Paper on February 1, 2005; DOI 10.1182/blood-2004-10-3955.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Brief report
Deficiency in the p110 subunit of PI3K results in diminished Tie2 expression and Tie2-/-like vascular defects in mice
Etienne Lelievre,
Pierre-Marie Bourbon,
Li-Juan Duan,
Robert L. Nussbaum, and
Guo-Hua Fong
From the Center for Vascular Biology, Departments of Cell Biology and Genetics and Developmental Biology, University of Connecticut Health Center, Farmington; and Genetic Diseases Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
Phosphoinositide 3-kinase (PI3K) is activated by transmembrane tyrosine kinases such as vascular endothelial growth factor (VEGF) receptors and Tie2 (tunica intima endothelial kinase 2), both of which are key regulators of vascular development. However, the in vivo role of PI3K during developmental vascularization remains to be defined. Here we demonstrate that mice deficient in the p110 catalytic subunit of PI3K display multiple vascular defects, including dilated vessels in the head, reduced branching morphogenesis in the endocardium, lack of hierarchical order of large and small branches in the yolk sac, and impaired development of anterior cardinal veins. These vascular defects are strikingly similar to those in mice defective in the Tie2 signaling pathway. Indeed, Tie2 protein levels were significantly lower in p110 -deficient mice. Furthermore, RNA interference of p110 in cultured endothelial cells significantly reduced Tie2 protein levels. These findings raise the possibility that PI3K may function as an upstream regulator of Tie2 expression during mouse development.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Brouillard and M. Vikkula
Genetic causes of vascular malformations
Hum. Mol. Genet.,
October 15, 2007;
16(R2):
R140 - R149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Chang, G. K. Sukhova, P. Libby, E. Schvartz, A. H. Lichtenstein, S. J. Field, C. Kennedy, S. Madhavarapu, J. Luo, D. Wu, et al.
Deletion of the phosphoinositide 3-kinase p110{gamma} gene attenuates murine atherosclerosis
PNAS,
May 8, 2007;
104(19):
8077 - 8082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K Riley and K. H Moley
Glucose utilization and the PI3-K pathway: mechanisms for cell survival in preimplantation embryos.
Reproduction,
May 1, 2006;
131(5):
823 - 835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Riley, M. O. Carayannopoulos, A. H. Wyman, M. Chi, and K. H. Moley
Phosphatidylinositol 3-Kinase Activity Is Critical for Glucose Metabolism and Embryo Survival in Murine Blastocysts
J. Biol. Chem.,
March 3, 2006;
281(9):
6010 - 6019.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|